Paul E Firuta Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul E Firuta.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul E Firuta. Paul E Firuta is President, US Comm Operations in NPS PHARMACEUTICALS INC ($NPSP) and Chief Operating Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and EVP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and Chief Commercial Officer in uniQure N.V. ($QURE).
Latest Insider Trading Transactions of Paul E Firuta
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACHN, NPSP, QURE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | EVP, Chief Commerci ... | Option Exercise | D | 2.18 | 200,000 | 436,000 | 0 | |
Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | EVP, Chief Commerci ... | Option Exercise | D | 3.32 | 400,000 | 1,328,000 | 0 | |
Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | Chief Operating Off ... | Option Exercise | A | 2.18 | 200,000 | 436,000 | 200,000 | |
Sep 12 2018 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | Chief Operating Off ... | Option Exercise | A | 3.32 | 400,000 | 1,328,000 | 400,000 | |
Jan 30 2018 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 19.39 | 22,843 | 442,926 | 22,843 | |
Jan 30 2018 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Grant | A | 0.00 | 8,566 | 0 | 93,817 | 85.3 K to 93.8 K (+10.05 %) |
Dec 15 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Grant | A | 0.00 | 56,115 | 0 | 56,115 | 0 to 56.1 K |
Jan 31 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 0.00 | 43,250 | 0 | 43,250 | |
Jan 31 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 5.37 | 43,250 | 232,253 | 43,250 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Firuta Paul E | President, US Comm ... | Option Exercise | D | 0.00 | 21,386 | 0 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Firuta Paul E | President, US Comm ... | Option Exercise | D | 0.00 | 10,905 | 0 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Firuta Paul E | President, US Comm ... | Option Exercise | D | 23.38 | 58,421 | 1,365,883 | 0 | |
Feb 24 2015 | NPSP | NPS PHARMACEUTICAL ... | Firuta Paul E | President, US Comm ... | Sell | U | 46.00 | 1,114 | 51,244 | 0 | 1.1 K to 0 (-100.00 %) |
Page: 1